ATE481638T1 - Methode zur messung der spezifizit t aktivierter lymphozyten - Google Patents

Methode zur messung der spezifizit t aktivierter lymphozyten

Info

Publication number
ATE481638T1
ATE481638T1 AT04802441T AT04802441T ATE481638T1 AT E481638 T1 ATE481638 T1 AT E481638T1 AT 04802441 T AT04802441 T AT 04802441T AT 04802441 T AT04802441 T AT 04802441T AT E481638 T1 ATE481638 T1 AT E481638T1
Authority
AT
Austria
Prior art keywords
specificity
activated lymphocytes
early
detect
present
Prior art date
Application number
AT04802441T
Other languages
English (en)
Inventor
Jun Hu
Original Assignee
Jun Hu
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jun Hu filed Critical Jun Hu
Application granted granted Critical
Publication of ATE481638T1 publication Critical patent/ATE481638T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • G01N33/56972—White blood cells

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Zoology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT04802441T 2003-12-08 2004-12-07 Methode zur messung der spezifizit t aktivierter lymphozyten ATE481638T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CNB2003101198721A CN1291231C (zh) 2003-12-08 2003-12-08 活化淋巴细胞特异性的检测方法
PCT/CN2004/001427 WO2005083427A1 (fr) 2003-12-08 2004-12-07 Procede d'essai de specification de l'activation de lymphocytes

Publications (1)

Publication Number Publication Date
ATE481638T1 true ATE481638T1 (de) 2010-10-15

Family

ID=34761430

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04802441T ATE481638T1 (de) 2003-12-08 2004-12-07 Methode zur messung der spezifizit t aktivierter lymphozyten

Country Status (8)

Country Link
US (1) US7829302B2 (de)
EP (1) EP1710580B1 (de)
JP (1) JP4444965B2 (de)
CN (1) CN1291231C (de)
AT (1) ATE481638T1 (de)
DE (1) DE602004029194D1 (de)
RU (1) RU2343486C2 (de)
WO (1) WO2005083427A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009028011A (ja) * 2007-07-30 2009-02-12 Kao Corp 細胞呼吸活性の測定方法及びそのキット、タンパク質生産性向上株のスクリーニング方法及びそのキット
RU2450274C1 (ru) * 2010-12-24 2012-05-10 Федеральное государственное учреждение науки "Государственный научный центр вирусологии и биотехнологии "Вектор" Федеральной службы по надзору в сфере защиты прав потребителей и благополучия человека (ФГУН ГНЦ ВБ "Вектор" Роспотребнадзора) Способ ранней диагностики заболевания геморрагической лихорадкой эбола у лиц, предположительно инфицированных указанным вирусом
CN104483376A (zh) * 2014-12-30 2015-04-01 青岛市市立医院 一种筛选环孢素a于免疫t细胞中药物作用靶位的方法
WO2019002689A1 (en) 2017-06-27 2019-01-03 Thermo Fisher Scientific Oy METHOD FOR ANALYZING LIQUID SAMPLES, MICRO-PLATE READER AND COMPUTER PROGRAM
WO2019172419A1 (ja) * 2018-03-09 2019-09-12 株式会社マンダム 免疫関連疾患の指標の検出方法
CN110804643B (zh) * 2019-10-29 2022-06-21 同济大学 一种体外评价卡介苗对中性粒细胞活性影响的方法
CN117741162A (zh) * 2024-02-20 2024-03-22 苏州才博医学科技有限公司 一种检测供者特异性抗体的细胞学方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4808151A (en) 1987-04-27 1989-02-28 E. I. Du Pont De Nemours And Company Simplified method for the preparation of human lymphokine activated killer cells
US5714585A (en) 1987-10-26 1998-02-03 Sterling Winthrop, Inc. Antibodies that are immunoreactive with interleukin-7
EP0624093A1 (de) * 1992-01-28 1994-11-17 KARPAS, Abraham Verwendung einer Verbindung zur Herstellung eines Arzneimittel zur Behandlung einer HIV-Infektion
CA2140591A1 (en) * 1994-01-20 1995-07-21 Josef Endl Antigen-specific, activated t lymphocytes, detection and use
US6150121A (en) * 1999-02-16 2000-11-21 Wisconsin Alumni Research Foundation Assessing immunological state of transplant recipients
US6346247B1 (en) * 1999-10-28 2002-02-12 Promega Corporation Prevention and treatment of autoimmune disease with luminally administered polyclonal antibodies
US7368257B2 (en) 2001-11-18 2008-05-06 Rigel Pharmaceuticals, Incorporated Modulators of lymphocyte activation, Mkk3b compositions and methods of use
US20030211548A1 (en) 2002-01-29 2003-11-13 Oncolmmunin, Inc. Visualization and quantitiation of cellular cytotoxicity using cell-permeable fluorogenic protease substrates and caspase activity indicator markers
ATE328279T1 (de) * 2002-08-23 2006-06-15 Deutsches Rheuma Forschungszen Verfahren zum nachweis und zur isolierung von t- lymphozyten, die ein definiertes antigen erkennen
CN1444043A (zh) * 2002-12-25 2003-09-24 帕弗瑞生物技术(北京)有限公司 一种个体化特异性免疫细胞功能测定方法

Also Published As

Publication number Publication date
JP4444965B2 (ja) 2010-03-31
EP1710580A1 (de) 2006-10-11
CN1627074A (zh) 2005-06-15
WO2005083427A1 (fr) 2005-09-09
CN1291231C (zh) 2006-12-20
RU2343486C2 (ru) 2009-01-10
EP1710580B1 (de) 2010-09-15
JP2007512816A (ja) 2007-05-24
RU2006124531A (ru) 2008-01-20
US7829302B2 (en) 2010-11-09
US20070172448A1 (en) 2007-07-26
EP1710580A4 (de) 2008-03-12
DE602004029194D1 (de) 2010-10-28

Similar Documents

Publication Publication Date Title
Egusa et al. An analysis of the persistent presence of opportunistic pathogens on patient-derived dental impressions and gypsum casts.
MX2012009906A (es) Metodos para diagnosticar patogenos de enfermedad infecciosa y su sensibilidad a farmaco.
McMahon et al. A potential hidden source of hepatitis C infection among noninjecting drug users
ATE481638T1 (de) Methode zur messung der spezifizit t aktivierter lymphozyten
Weesendorp et al. Transmission of classical swine fever virus depends on the clinical course of infection which is associated with high and low levels of virus excretion
McGinnis et al. In vitro evaluation of the susceptibility of Edwardsiella ictaluri, etiological agent of enteric septicemia in channel catfish, Ictalurus punctatus (Rafinesque), to florfenicol
ATE529743T1 (de) Verfahren und kits zur tumorigenizitätsdiagnose
Garbin et al. Hepatitis C virus and dental health workers: an update
Ghosh et al. Role of saliva as a non-invasive diagnostic method for detection of COVID-19
MD34Z5 (ro) Metodă de diagnostic al hepatitei virale B la copii de până la un an
FR2973109B1 (fr) Methode cytologique utilisant l'autofluorescence des globules blancs pour le diagnostic precoce et le suivi des infections
Sadikoglu et al. Saliva: Both a Threat and an Opportunity in Covid-19 Pandemic
A-elgayoum et al. Towards a noninvasive approach to malaria diagnosis: detection of parasite DNA in body secretions and surface mucosa
Lopez-Verdin et al. Screening Test for COVID-19 in Dentai Practice: Best Options
Kashiwabara et al. Denture plaque microflora in geriatric inpatients and maxillary defect patients
Block et al. Diagnosis and management of acute otitis media
Pal et al. Rhodococcus equi: An emerging zoonotic pathogen
Gorji et al. Viral contamination of acrylic resin removable denture bases in patients with COVID-19: A cross-sectional study
Supratim et al. Role of Saliva as a Non-Invasive Diagnostic Method for Detection of COVID-19
Srivastava et al. Protocols for dentists during Covid-19 pandemic
US20050071892A1 (en) Techniques and applications of establishment of SARS-CoV primate model
CN1468955A (zh) 一种新型冠状病毒
Suzuki et al. Negative effects of pre‐admission screening with simplified multiplex PCR.
Caymaz Saliva: Both a Threat and an Opportunity in Covid-19 Pandemic
Hussein Spread of COVID-19 in Dental setting (an article review)

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties